文献速递消化内镜消化道肿瘤与早癌

大型无蒂结直肠息肉不完全切除后残留肿瘤的内镜黏膜下剥离术临床结局:大型多中心倾向匹配研究

Clinical outcomes of endoscopic submucosal dissection for residual neoplasia after incomplete resection of large nonpedunculated colorectal polyps: a large multicenter propensity match study (with video).
PubMed 文献 · Gastrointest Endosc · 2025-07-22

本研究为多中心倾向评分匹配研究,比较治疗初治与既往内镜切除失败后残留肿瘤的大肠无蒂息肉行内镜黏膜下剥离术的结局。匹配后初治组361例与失败组184例,整块切除率、R0切除率、穿孔率及肿瘤复发率均无显著差异,失败组迟发出血有升高趋势但未达统计学意义。结论认为内镜黏膜下剥离术可作为内镜切除失败后的安全有效补救治疗。

要点

  • 内镜黏膜下剥离术用于大肠无蒂息肉内镜切除失败后残留肿瘤安全有效。
  • 匹配后整块切除率91.7%对89.7%、R0切除率80.9%对81.0%均无显著差异。
  • 失败组迟发出血有升高趋势但未达统计学意义,穿孔率无差异。

核心结论

  • 内镜黏膜下剥离术可作为大型无蒂结直肠息肉内镜切除失败后残留肿瘤的安全有效补救治疗。
  • 研究结果支持现行指南推荐对内镜不完全切除后残留肿瘤采用内镜黏膜下剥离术。

研究设计与样本

  • 多中心倾向评分匹配研究,纳入2021年1月至2024年9月因大型无蒂结直肠息肉行内镜黏膜下剥离术的连续患者1447例。
  • 倾向评分协变量包括年龄、性别及病变特征(大小、位置、形态、组织学),匹配后初治组361例与既往内镜切除失败组184例按2:1严格配对。

主要发现

  • 初治组与既往内镜切除失败组的穿孔率分别为4.7%与4.4%(P=1.00)。

临床怎么用

  • 对于大型无蒂结直肠息肉内镜切除不完全后的残留肿瘤,可选择性考虑内镜黏膜下剥离术作为补救治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Data on endoscopic submucosal dissection (ESD) for residual neoplasia after incomplete endoscopic resection (ER) of large nonpedunculated colorectal polyps (LNPCPs) remain scarce. We aimed to evaluate and compare outcomes of ESD in patients with treatment-naïve (control) lesions versus those with previous failed ER. METHODS: This was a multicenter propensity-score (PS) match study of ESDs performed for LNPCPs between January 2021 and September 2024. The following covariates were used for PS calculation: age, sex, and lesion characteristics (size, location, morphology, histology). End points included rates of en bloc and R0 resection, adverse events, and neoplasia recurrence on surveillance. RESULTS: A total of 1447 consecutive patients underwent ESD during the study period. PS match resulted in the selection of 361 (control) and 184 (previous failed ER) strictly matched 2:1 pairs. En bloc and R0 resection rates were similar between the control and previous failed ER arms: 91.7% versus 89.7%; P = .44 and 80.9% versus 81.0%; P = .98, respectively. There was no difference in the rate of perforation between the control and previous failed ER arms (4.7% vs 4.4%; P = 1.00), whereas there was a nonstatistically significant trend toward greater delayed bleeding in the previous failed ER group (1.63% vs 0.83%, relative risk: 1.96; P = .40). Neoplasia recurrence on surveillance was 3.6% in the control and 5.8% in the previous failed ER group (P = .32). CONCLUSIONS: ESD can be performed safely and effectively as a salvage therapy after failed attempt at ER of LNPCPs. ESD may be selectively considered as part of our endoscopic armamentarium for the management of these difficult-to-treat lesions. Our findings reinforce current guideline recommendations that endorse the use of ESD for managing residual neoplasia following an incomplete ER.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Robalino Gonzaga E, Zhang Y, Mohammed AS, et al. Clinical outcomes of endoscopic submucosal dissection for residual neoplasia after incomplete resection of large nonpedunculated colorectal polyps: a large multicenter propensity match study (with video). Gastrointest Endosc. 2025. PMID: 40706906. doi:10.1016/j.gie.2025.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。